Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets

Glioblastoma (GBM) is the most common and malignant primary brain cancer in adults. Without treatment the mean patient survival is approximately 6 months, which can be extended to 15 months with the use of multimodal therapies. The low effectiveness of GBM therapies is mainly due to the tumor infilt...

Descripción completa

Detalles Bibliográficos
Autores principales: Erices, José Ignacio, Bizama, Carolina, Niechi, Ignacio, Uribe, Daniel, Rosales, Arnaldo, Fabres, Karen, Navarro-Martínez, Giovanna, Torres, Ángelo, San Martín, Rody, Roa, Juan Carlos, Quezada-Monrás, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139189/
https://www.ncbi.nlm.nih.gov/pubmed/37108208
http://dx.doi.org/10.3390/ijms24087047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139189/
https://www.ncbi.nlm.nih.gov/pubmed/37108208
http://dx.doi.org/10.3390/ijms24087047

Ejemplares similares